Tag

Kuvan (sapropterin) is the first treatment approved for hyperphenylalaninemia due to the rare metabolism disorder phenylketonuria (PKU) and has orphan drug exclusivity in Europe until 2020. By returning the rights to BioMarin, Merck is confident that the product will continue to...

Meanwhile, investors continued to assess the US Federal Reserve’s decision to leave short-term interest rates unchanged.

The Federal Reserve’s decision to delay an interest rate increase last week was largely a “risk management” exercise to be sure recent market volatility would not become a drag on the economy, Atlanta Fed President Dennis Lockhart said on Monday.

A diabetes drug sold by Eli Lilly & Co. and Boehringer Ingelheim GmbH lowered the risk of heart attacks, stroke and death in a large trial of adults with type 2 diabetes, compared with the standard of care alone. All patients were considered at high risk of heart attacks and...

A vaccine for the Ebola virus – the first of its kind in the disease’s 40-year recorded history – shows promise in trials in Guinea, according to a report released Friday in the medical journal Lancet.

Those involved in funding the trial called it a “remarkable” result and said the co-operation between organisations and countries that allowed it to come about augured well for future outbreaks of unsafe viruses.

“The “ring” vaccination method adopted for the vaccine trial is based on the smallpox eradication strategy”, John-Arne Røttingen, M.D., Ph.D., director of the division of infectious disease control at the Norwegian Institute of Public Health and chair of...

The British medical journal Lancet has published early test results and analyses of the findings.

At this point no country would consider vaccinating all its children against Ebola, for example.

In comparing the stock’s current level to its extended history, the stock is trading -10.115% away from its 52-week high of 63.620 and +8.945% away from the stock’s low point over the past 52 weeks, which was 52.490. The sale was disclosed in a document filed with the...

The grocery store operator posted revenue of $5.41 billion in the period, which met Street forecasts. Analysts had predicted $273 million.